Sep 29, 2026 07:32AM
Sep 29, 2026 07:30AM
Sep 3, 2026 08:33AM
Sep 3, 2026 08:30AM
Apr 28, 2026 08:00AM
Mar 18, 2026 09:00AM
Mar 18, 2026 08:15AM Red Light Holland Engages Kala Bio's Researgency.ai Platform to Support Clinical Development of Filament Health's Patented PEX010 Botanical Psilocybin Drug Candidate
Mar 11, 2026 10:00AM
Dec 1, 2025 07:01AM
Dec 1, 2025 07:00AM
Sep 2, 2025 08:00AM
Sep 2, 2025 08:00AM
Sep 2, 2025 08:00AM
Aug 8, 2025 08:00AM KALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate Update
May 14, 2025 08:00AM
Mar 31, 2025 08:00AM
Nov 12, 2024 08:00AM
Aug 6, 2024 08:00AM
May 14, 2024 04:05PM
Mar 29, 2024 08:00AM
Nov 13, 2023 08:00AM KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Aug 4, 2023 08:00AM
May 9, 2023 08:00AM
Mar 3, 2023 08:02AM
Mar 3, 2023 08:00AM
Mar 3, 2023 08:00AM
Nov 8, 2022 08:00AM
Nov 8, 2022 08:00AM Kala Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Aug 11, 2022 07:00AM
Aug 11, 2022 07:00AM
May 16, 2022 07:00AM
May 16, 2022 07:00AM
May 3, 2022 08:03AM
May 3, 2022 08:00AM
May 3, 2022 08:00AM Kala Pharmaceuticals Announces New Commercial and Medicare Coverage for EYSUVIS®
May 1, 2022 09:00AM
May 1, 2022 09:00AM
Mar 29, 2022 07:04AM
Mar 29, 2022 07:00AM
Mar 29, 2022 07:00AM
Mar 8, 2022 08:10AM
Mar 8, 2022 08:00AM Kala Pharmaceuticals Announces EYSUVIS® Now Covered on UnitedHealthcare Commercial and Cigna Medicare
Mar 8, 2022 08:00AM
Dec 15, 2021 06:25AM
Nov 18, 2021 04:01PM
Nov 18, 2021 04:01PM
Nov 15, 2021 08:47AM
Nov 15, 2021 08:47AM
Nov 15, 2021 08:45AM Kala Pharmaceuticals (KALA) Acquires Combangio
Nov 15, 2021 08:45AM

1,196,373 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All